Financings in Brief: Meridian Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Meridian Diagnostics: Immunodiagnostic kit manufacturer files registration statement with SEC for an offering of convertible subordinated debentures worth a principal amount of $12.5 mil. Net proceeds from the offering will be used for "possible acquisitions and licensing of products or technologies and general corporate purposes," Meridian says. Underwriters Roney & Co. will receive an over-allotment option to buy $1.9 mil. in convertible debentures...